Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 2
2000 1
2005 1
2006 1
2007 2
2013 1
2014 1
2017 3
2018 3
2019 2
2020 4
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial.
Blauvelt A, Papp K, Gottlieb A, Jarell A, Reich K, Maari C, Gordon KB, Ferris LK, Langley RG, Tada Y, Lima RG, Elmaraghy H, Gallo G, Renda L, Park SY, Burge R, Bagel J; IXORA-R Study Group. Blauvelt A, et al. Br J Dermatol. 2020 Jun;182(6):1348-1358. doi: 10.1111/bjd.18851. Epub 2020 Jan 15. Br J Dermatol. 2020. PMID: 31887225 Free PMC article. Clinical Trial.
Excimer laser in the treatment of mycosis fungoides.
Deaver D, Cauthen A, Cohen G, Sokol L, Glass F. Deaver D, et al. Among authors: cauthen a. J Am Acad Dermatol. 2014 Jun;70(6):1058-60. doi: 10.1016/j.jaad.2014.01.915. Epub 2014 Apr 26. J Am Acad Dermatol. 2014. PMID: 24775402
Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: Results of a phase 3b, multicenter, randomized, placebo-controlled, double-blind study.
Van Voorhees AS, Stein Gold L, Lebwohl M, Strober B, Lynde C, Tyring S, Cauthen A, Sofen H, Zhang Z, Paris M, Wang Y. Van Voorhees AS, et al. Among authors: cauthen a. J Am Acad Dermatol. 2020 Jul;83(1):96-103. doi: 10.1016/j.jaad.2020.01.072. Epub 2020 Feb 4. J Am Acad Dermatol. 2020. PMID: 32032692 Free article. Clinical Trial.
Construction of mouse adenovirus type 1 mutants.
Cauthen AN, Welton AR, Spindler KR. Cauthen AN, et al. Methods Mol Med. 2007;130:41-59. doi: 10.1385/1-59745-166-5:41. Methods Mol Med. 2007. PMID: 17401163
19 results